These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21204814)

  • 1. Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study.
    Sahaya K; Goyal MK; Sarwal A; Singh NN
    Epilepsia; 2010 Dec; 51(12):2492-5. PubMed ID: 21204814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
    Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW
    Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia during levetiracetam therapy.
    Meschede A; Runge U; Sabolek M
    Epilepsy Res; 2008 Jul; 80(1):91-2. PubMed ID: 18424076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of levetiracetam-induced thrombocytopenia.
    Oghlakian R; Nock C; Koubeissi M
    Epileptic Disord; 2010 Dec; 12(4):335-7. PubMed ID: 21078583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocytopenia as an adverse effect of levetiracetam therapy in a child.
    Peer Mohamed B; Prabhakar P
    Neuropediatrics; 2009 Oct; 40(5):243-4. PubMed ID: 20221962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy.
    Rocamora R; Wagner K; Schulze-Bonhage A
    Seizure; 2006 Sep; 15(6):428-33. PubMed ID: 16837220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
    Milligan TA; Hurwitz S; Bromfield EB
    Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study.
    Peltola J; Peltola M; Auvinen A; Keränen T; Liimatainen S; Kharazmi E; Fallah M
    Acta Neurol Scand; 2008 May; 117(5):332-6. PubMed ID: 18081915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of levetiracetam in hospitalized patients.
    Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam in refractory epilepsy: a prospective observational study.
    Mohanraj R; Parker PG; Stephen LJ; Brodie MJ
    Seizure; 2005 Jan; 14(1):23-7. PubMed ID: 15642496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects.
    Brodtkorb E; Klees TM; Nakken KO; Lossius R; Johannessen SI
    Epilepsy Behav; 2004 Apr; 5(2):231-5. PubMed ID: 15123025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam-induced thrombocytopenia.
    Kimland E; Höjeberg B; von Euler M
    Epilepsia; 2004 Jul; 45(7):877-8. PubMed ID: 15230717
    [No Abstract]   [Full Text] [Related]  

  • 15. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
    von Stuelpnagel C; Holthausen H; Kluger G
    Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hair loss with levetiracetam in five patients with epilepsy.
    Zou X; Hong Z; Zhou D
    Seizure; 2014 Feb; 23(2):158-60. PubMed ID: 24315496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva and serum levetiracetam concentrations in patients with epilepsy.
    Mecarelli O; Li Voti P; Pro S; Romolo FS; Rotolo M; Pulitano P; Accornero N; Vanacore N
    Ther Drug Monit; 2007 Jun; 29(3):313-8. PubMed ID: 17529888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C; Rubio G
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.